Deflazacort

228 interactions 335 cited references
Also sold as: Emflaza Emflaza® Jaythari Kymbee Pyquvi
About Deflazacort

Deflazacort is used to treat Duchenne muscular dystrophy (DMD; a progressive disease in which the muscles do not function properly) in adults and children 2 years of age and older. Deflazacort is in a class of medications called corticosteroids. It works by reducing inflammation (swelling) and by changing the way the i… Read the full Deflazacort drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Deflazacort Droxicam Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Efavirenz Decreased exposure to active metabolite of deflazacort Details Deflazacort Enoxacin An increased risk of tendon rupture Details Deflazacort Enzalutamide Xtandi Decreased exposure to active metabolite of deflazacort Details Deflazacort Erythromycin Erythrocin Stearate Increased exposure to active metabolite of deflazacort Details Deflazacort Ethinyl Estradiol Increased corticosteroid exposure Details Deflazacort Etodolac Lodine Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Etofenamate Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Etoricoxib Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Etravirine Intelence Decreased exposure to active metabolite of deflazacort Details Deflazacort Felbinac Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Fenoprofen Fenopron Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Fepradinol Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Feprazone Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Fleroxacin An increased risk of tendon rupture Details Deflazacort Floctafenine Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Fluconazole Diflucan Increased exposure to active metabolite of deflazacort Details Deflazacort Flufenamic Acid Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Flumequine An increased risk of tendon rupture Details Deflazacort Flurbiprofen Ansaid Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Fluvoxamine Increased exposure to active metabolite of deflazacort Details Deflazacort Fosphenytoin Cerebyx Decreased exposure to active metabolite of deflazacort Details Deflazacort Gatifloxacin Zymaxid An increased risk of tendon rupture Details Deflazacort Gemifloxacin Factive An increased risk of tendon rupture Details Deflazacort Ibuprofen Addaprin Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Idelalisib Zydelig Increased exposure to active metabolite of deflazacort Details Deflazacort Imatinib Gleevec Increased exposure to active metabolite of deflazacort Details Deflazacort Indinavir Increased exposure to active metabolite of deflazacort Details Deflazacort Indomethacin Indocin Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Insulin Aspart, Recombinant Fiasp Reduced blood glucose lowering effect of insulin Details Deflazacort Insulin Glargine, Recombinant Basaglar Reduced blood glucose lowering effect of insulin Details Deflazacort Insulin Icodec-Abae Awiqli Reduced efficacy of insulin icodec-abae Details Deflazacort Itraconazole Sporanox Increased exposure to active metabolite of deflazacort Details Deflazacort Ketoconazole Extina Increased exposure to active metabolite of deflazacort Details Deflazacort Ketoprofen Actron® Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Ketorolac Acular Increased risk of gastrointestinal ulcer or bleeding Details Deflazacort Letermovir Prevymis Increased exposure to active metabolite of deflazacort Details Deflazacort Levofloxacin Levaquin An increased risk of tendon rupture Details Deflazacort Lomefloxacin An increased risk of tendon rupture Details Deflazacort Lopinavir Increased exposure to active metabolite of deflazacort Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.